HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions.
Pharmaceutical distributor sales reached $758 billion amid some of the lowest profit margins in the study’s 95-year history — 0.3 percent (net after taxes) and 1.7 percent (gross) in 2023.
“HDA and our pharmaceutical distributor members applaud the FDA’s decision to grant an exemption for the DSCSA’s enhanced drug distribution security (EDDS) requirements for eligible trading partners."
